![](https://investorshub.advfn.com/uicon/171609.png?cb=1653151642)
Tuesday, March 15, 2022 8:23:01 PM
First, saying it again: I appreciate you, and thank you for your thoughtful contributions.
Second, I thought the same re the timeline on finalizing these regulations & guidelines, expecting it would be sooner, definitely thinking by 2021 year’s end … tho with less basis for my opinion than yours :)
In my experience, but not FDA-related, I’m a bit familiar with the agency rulemaking process, federal register publication, comment submission periods, etc, preceding finalizing revised regulations. So I guess the surprise here for the wait, as I’ve not seen anything like this long process.
Sorta analogously, but from experience, I do understand how strong the BP lobby is, not that I’m inferring anything here. There was a period in my career when I, together with a number of my contemporaries/colleagues from different corporations, were meeting with members of Congress, on both sides of the House, re a particularly significant legislative reformation effort. We were a fairly high level corporate delegation. It was surprising and eye opening as well.
This legislative effort had bipartisan support on the House of Reps side, but when discussions with Senators and their Legistative Directors (LD) then ensued, it became apparent the legislative reform supported by corporate America writ large, would die. Why, one can really never know, but during a subsequent, and private conversation I had with a key senator’s LD, I sorta clearly sensed that if BP didn’t support legislative reform here on the Senate side, it was doomed; and it died. One of my colleagues (and former clients) was head of a big corp organization, similar to mine, different industry. He was there at these meetings and we had many shared corporate interests, but not all apparently. He subsequently became the executive Director of PhRMA. Looking back, for me, the bottom line is BP is (to me) incomprehensibly powerful and not to be taken lightly.
Through that experience and subsequent investments, a lot can fit in about why NWBO management may be proceeding with cards closely held. I have a sense of the power & capabilities of BP. Any sophisticated David, versus a Goliath, would be foolish not to tread very carefully. There could be many answers re what’s going on within NEBO and this excruciating “quiet period”, but I’d never discount the fact that there are big powerful forces working to blunt NWBO’s objective and possibly provide a rationale for what we’re watching on the sidelines.
Cap
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM